The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
909
November 12, 1993
View Complete Issue         Table of Contents 2019 
Butorphanol Nasal Spray for Pain
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Butorphanol Nasal Spray for Pain
November 12, 1993 (Issue: 909)
Butorphanol tartrate, a synthetic opioid agonist-antagonist analgesic previously available for injection, is now being marketed as a nasal spray (Stadol-NS - Mead Johnson). The spray was approved by the US Food and Drug Administration (FDA) for ...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Butorphanol Nasal Spray for Pain
Article code: 909c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.